| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |